RLAY
Relay Therapeutics Inc
NASDAQ: RLAY · HEALTHCARE · BIOTECHNOLOGY
$12.57
-3.53% today
Updated 2026-04-29
Market cap
$2.41B
P/E ratio
—
P/S ratio
156.64x
EPS (TTM)
$-1.61
Dividend yield
—
52W range
$3 – $17
Volume
3.0M
Relay Therapeutics Inc (RLAY) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $428.61M | $393.07M | $799.83M | $1.01B | $1.10B | $843.98M | $871.30M |
| Cash & equivalents | $421.50M | $41.95M | $447.65M | $280.12M | $998.92M | $143.74M | $124.29M |
| Current assets | $424.10M | $360.54M | $770.10M | $976.24M | $1.02B | $770.10M | $809.20M |
| Total liabilities | $539.54M | $573.51M | $36.54M | $110.64M | $149.55M | $91.98M | $93.50M |
| Current liabilities | $6.87M | $11.99M | $13.63M | $24.32M | $63.71M | $30.27M | $50.73M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | $-110.93M | $-180.44M | $763.29M | $897.81M | $950.22M | $752.00M | $777.79M |
| Retained earnings | $-114.18M | $-189.48M | $-404.23M | $-768.10M | $-1.06B | $-1.40B | $-1.74B |
| Accounts receivable | — | — | $82.65M | $4.94M | $5.22M | $0.00 | — |
| Inventory | — | — | $-238.07M | $-682.49M | $12.11M | — | — |
| Goodwill | — | — | — | — | — | — | — |